Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Drug Development Collaborations (Details Narrative)

v3.5.0.2
3. Significant Strategic Drug Development Collaborations (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Significant Strategic Drug Development Collaborations - Related Parties    
Income from collaborative agreements $ 0 $ 0